SPIA
MDNA

Steward Partners Investment Advisory’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Steward Partners Investment Advisory’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,666
Closed -$2K – 3423
2022
Q1 		$2K Hold
1,666
– – ﹤0.01% 3140
2021
Q4 		$3K Hold
1,666
– – ﹤0.01% 2988
2021
Q3 		$5K Buy
+1,666
New +$4.13K ﹤0.01% 2834

Other funds holding MDNA

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Steward Partners Investment Advisory's MDNA Position: Q2 2022 in Review

Steward Partners Investment Advisory sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q2 2022, closing a stake of 1,666 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in MDNA in Q3 2021 and held it in 3 quarters. The position peaked at $5K in Q3 2021. 19 funds tracked by Wall St. Rank hold MDNA as of Q2 2022.

  • Steward Partners Investment Advisory reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q2 2022 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,666 Medicenna Therapeutics Corp. Common Shares shares in Q2 2022, an estimated $2K.
  • Steward Partners Investment Advisory first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2021 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Medicenna Therapeutics Corp. Common Shares position peaked at $5K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q2 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2022, filed 4 Aug 2022.